An automated external defibrillator or AED is a portable and lightweight medical device that delivers an electric shock through the chest to heart. It is used for cure of sudden cardiac arrest or cardiac arrest, which generally occurs with a disruption in the heart’s electrical activity. AED is also known as public access defibrillators (PADs), as it can be used by anyone during an emergency.
According to study, “Global Automated External Defibrillator (AED) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” the key companies operating in the global AED market are Koninklijke Philips NV, Laerdal Medical, Zoll Medical Corporation (Asahi Kasei Corporation), Nihon Kohden Corp., Physio-Control, HeartSine Technologies, Cardiac Science Corporation (Aurora Capital Group), Metrax GmbH, Biotronik Se & Co.Kg, Schiller, METsis Medikal, A.M.I. Italia, Physio-Control International, Inc., Sorin Group (Now Livanova PLC), Beijing M&B Electronic, Defibtech, Shenzhen XFT, Mediana, Mindray, Instramed.
Based on type, AED market is segmented into wearable and non-wearable. Non-wearable segment dominate the market as it is easy to handle, user-friendly, and require less maintenance. Based on technology type, market is segmented into semi-automated external defibrillators (SAED) and fully automated external defibrillator (FAED). The major difference between a SAED and FAED is that the FAED sends a shock automatically to the heart, after vocally preparing the patient to receive the shock while SAED allows the patient to take the resolution of sending a shock, after vocally requesting them. Semi-automatic external defibrillators segment is projected to witness higher growth rate owing to rise in geriatric population and increase in per capita income during the forecast period. Based on size, market is segmented into pediatric automated external defibrillator and standard automated external defibrillator. Standard automated external defibrillator holds major share in market due to high prevalence of sudden cardiac arrest in adults. In addition, based on end-user, market is segmented into hospitals, emergency medical services, homes, public access, work spaces, and private cardiac clinics.
The AED market is driven by growth in technological advancements in automated defibrillators, followed by rapid growth in aging population, increase in focus to provide public access defibrillators and rise in prevalence in cardiovascular diseases. However, lack of awareness & early corrective measures about Sudden Cardiac Arrest (SAC) and stringent regulations may impact the market. Moreover, increase in investments by private players is a key opportunity for market.
Based on geography, the North-American region holds major share in AED market, followed by European region owing to rise in advancements in medical technology and increase in several cardio-vascular diseases in the region. The Asian-Pacific region is expected to witness lucrative growth rate due to rise in investment by market players and growth in prevalence sudden cardiac arrest over the forecast period. In near future, it is predicted that the market will be reached at fast speed because of increase in advantages of automated external defibrillators and rise in awareness among consumers about the safe use during the forecast period. The global market is anticipated to grow at a CAGR of approximately 5.4% over the next five years, will reach US $930 million in 2024, from US $680 million in 2019.
For More Information on the research report, refer to below link:-
Ankur Gupta, Head Marketing & Communications